## Abstract ## Background: Thrombotic microangiopathy (TMA) encompasses a number of disorders with hemolytic anemia and thrombocytopenia, including thrombotic thrombocytopenic purpura (TTP). A deficiency in ADAMTS13 enzyme levels, along with an inhibitory antibody, is found in most patients with i
✦ LIBER ✦
Human Immunodeficiency Virus-Associated Thrombotic Microangiopathies: Clinical Characteristics and Outcome According to ADAMTS13 Activity
✍ Scribed by S. Malak; M. Wolf; G. A. Millot; E. Mariotte; A. Veyradier; J.-L. Meynard; J.-M. Korach; S. Malot; A. Bussel; E. Azoulay; E. Boulanger; L. Galicier; E. Devaux; V. Eschwège; S. Gallien; C. Adrie; B. Schlemmer; E. Rondeau; P. Coppo; for the Réseau d’Etude des Microangiopathies Thrombotiques (TMA-Rare Diseases Reference Center)
- Book ID
- 110861664
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 149 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0300-9475
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
ADAMTS13 activity levels in patients wit
✍
Yara A. Park; Shauna N. Hay; Mark E. Brecher
📂
Article
📅
2009
🏛
John Wiley and Sons
🌐
English
⚖ 110 KB